PRRT2 and neoplasm: Pb competes for Ca2+ binding sites on key proteins such as calmodulin (CaM), protein kinase C (PKC), and synaptic proteins and troponin C. Activation of PKC by picomolar concentrations of Pb2+ can lead to aberrant activation of transcription factors and act as a tumor promoter [391,392].